Hepatitis Australia, 3 April 2020 Hepatitis Australia warmly welcomes recent changes to the Pharmaceutical Benefits Scheme (PBS) allowing authorised Nurse Practitioners to prescribe hepatitis B and hepatitis C medicines under the Highly Specialised Drugs (s100) Program. Both hepatitis B and hepatitis C are under-treated and without improvement in a range of areas Australia risks falling short of...
CATIE (Canada), 17 March 2020 An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19 A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19 People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with...
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), June 2019 This Deadly Sex Update webinar provides Aboriginal and Torres Strait Islander health and community workers with an introduction and the latest news in hepatitis C and HIV. The information presented supports health workers to discuss key messages with clients and the community around hep C and HIV, including...
SA Health, updated 2019
Deciding to disclose your HIV or viral hepatitis (hepatitis B or hepatitis C) status is a personal choice. There are few situations where you are legally required to disclose your HIV or viral hepatitis status, however, there may be times when it’s in your best interests to disclose your status even if you are not legally required to do so.
Read more here
Adelaide Sexual Health Centre , October 2019 Adelaide Sexual Health Centre presents Stepping Out: Living Healthy & Long, an HIV & Sexual Health Update for Nurses and Aboriginal Health Workers in South Australia. With the generous support of an unconditional education grant from ViiV Healthcare, ASHC is able to provide a seminar at no cost to the participant, hosted in central Adelaide...
International Journal of Drug Policy, Volume 72,Pages 1-198 (October 2019) Nearly 200 pages of open access articles from projects and research around the world. While this special issue highlights some successful efforts towards HCV elimination among people who inject drugs, it also highlights the relative lack of attention to settings in which resources enabling elimination are scarce, and where...